Epidemiology of Clinically Relevant Bacteria and Antimicrobial Resistance

Dear Colleagues,

Antimicrobial resistance (AMR) is a global concern, with increasing rates of multi-drug-resistant (MDR) pathogens reported clinically. Antibiotic resistance to last-line antibiotics including carbapenems, colistin and tigecycline is rising, as are reports of bacteria acquiring multiple plasmids or mobile genetic elements; thus multiple classes of antibiotics have been rendered ineffective. The social, economic and health costs of AMR are, however, unequally felt across the world, largely because of the variable risk of infections according to factors such as overcrowding, access to clean water, sanitation conditions and poverty.

This Special Issue welcomes article submissions that feature clinically relevant bacteriology research and studies on antimicrobial resistance. Articles focusing on sepsis/blood stream infections or that cover a ‘One Health Approach’, including clinical samples or research from low–middle-income countries (LMICs), are particularly encouraged. Original research articles, review articles and method-based articles will be considered. Original research articles must include both epidemiological/clinical data and either phenotypic or genotypic profiling. Review articles must be centrally focused on antimicrobial resistance topics. Method articles must advance and/or focus on laboratory/informatics approaches relevant to antibiotic resistance research. 

Dr. Kirsty Sands
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• antimicrobial resistance
• antibiotic susceptibility testing
• clinical infection
• gram-negative bacteria
• gram-positive bacteria
• microbial epidemiology
• multi-drug resistance
• microbial genomics